BlinkLab
Announcements

Read our recent announcements about our company, our research, and partnerships.

In the news

November 19, 2025

ASX biotech IPOs - 10-year performance and outlook

Read the article
September 17, 2025

BlinkLab (ASX:BB1) has announced the addition of the Thompson Center for Autism and Neurodevelopment at the University of Missouri as the sixth US clinical site for its pivotal FDA 510(k) diagnostic trial.

Read the article
August 14, 2025

Morgans spotlights nine healthcare stocks with upcoming catalysts

Read the article
July 7, 2025

BlinkLab's AI-Powered Autism Diagnostic Tool: A Game-Changer in a $5.41B Market?

Read the article

Read all announcements

Want to feature BlinkLab?

We are more than happy to assist you with that. If you need any assets, insights or want to request an interview — feel free to reach out to Henk-Jan, our CEO.

Send Henk-Jan an email
Henk-Jan Boele BlinkLab CEO